Investigational therapies for the treatment of spinal muscular atrophy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigational therapies for the treatment of spinal muscular atrophy
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 24, Issue 7, Pages 867-881
Publisher
Informa Healthcare
Online
2015-04-25
DOI
10.1517/13543784.2015.1038341
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PTEN Depletion Decreases Disease Severity and Modestly Prolongs Survival in a Mouse Model of Spinal Muscular Atrophy
- (2015) Daniel Little et al. MOLECULAR THERAPY
- Assays for the Identification and Prioritization of Drug Candidates for Spinal Muscular Atrophy
- (2014) Jonathan J. Cherry et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Oligonucleotide-based therapy for neurodegenerative diseases
- (2014) Iddo Magen et al. BRAIN RESEARCH
- The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice
- (2014) Matthew E.R. Butchbach et al. EXPERIMENTAL NEUROLOGY
- Oligonucleotide delivery: a patent review (2010 – 2013)
- (2014) Santiago Grijalvo et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Gene Therapy: A Promising Approach to Treating Spinal Muscular Atrophy
- (2014) Pádraig J. Mulcahy et al. HUMAN GENE THERAPY
- SMN regulates axonal local translation via miR-183/mTOR pathway
- (2014) Min Jeong Kye et al. HUMAN MOLECULAR GENETICS
- Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy
- (2014) Thomas M. Wishart et al. JOURNAL OF CLINICAL INVESTIGATION
- G.O.17
- (2014) R.S. Finkel et al. NEUROMUSCULAR DISORDERS
- VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models
- (2014) Jeremiah Hadwen et al. Orphanet Journal of Rare Diseases
- SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy
- (2014) N. A. Naryshkin et al. SCIENCE
- ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets
- (2014) Emmanuelle Coque et al. Frontiers in Neuroscience
- How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches
- (2013) Brunhilde Wirth et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Histone Acetylation as a Potential Therapeutic Target in Motor Neuron Degenerative Diseases
- (2013) Lutz Garbes et al. CURRENT PHARMACEUTICAL DESIGN
- Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds
- (2013) Jonathan J. Cherry et al. EMBO Molecular Medicine
- A Novel Morpholino Oligomer Targeting ISS-N1 Improves Rescue of Severe Spinal Muscular Atrophy Transgenic Mice
- (2013) Haiyan Zhou et al. HUMAN GENE THERAPY
- The DcpS inhibitor RG3039 improves motor function in SMA mice
- (2013) James P. Van Meerbeke et al. HUMAN MOLECULAR GENETICS
- The Neuroprotective Drug Riluzole Acts via Small Conductance Ca2+-Activated K+ Channels to Ameliorate Defects in Spinal Muscular Atrophy Models
- (2013) M. Dimitriadi et al. JOURNAL OF NEUROSCIENCE
- SMA valiant trial: A prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy
- (2013) John T. Kissel et al. MUSCLE & NERVE
- O.9 First-in-human phase I study to assess safety, tolerability and dose for intrathecal injection of ISIS-SMNRx in SMA patients
- (2013) K. Swoboda et al. NEUROMUSCULAR DISORDERS
- Somatropin treatment of spinal muscular atrophy: A placebo-controlled, double-blind crossover pilot study
- (2013) J. Kirschner et al. NEUROMUSCULAR DISORDERS
- Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy
- (2012) Melissa Bowerman et al. BMC Medicine
- Spinal muscular atrophy: The role of SMN in axonal mRNA regulation
- (2012) Claudia Fallini et al. BRAIN RESEARCH
- Therapeutic strategies for the treatment of spinal muscular atrophy
- (2012) Jonathan J Cherry et al. Future Medicinal Chemistry
- VPA response in SMA is suppressed by the fatty acid translocase CD36
- (2012) L. Garbes et al. HUMAN MOLECULAR GENETICS
- Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality
- (2012) Bastian Ackermann et al. HUMAN MOLECULAR GENETICS
- The specific VPAC2 agonist Bay 55-9837 increases neuronal damage and hemorrhagic transformation after stroke in type 2 diabetic rats
- (2012) Vladimer Darsalia et al. NEUROPEPTIDES
- Analysis of a read-through promoting compound in a severe mouse model of spinal muscular atrophy
- (2012) Virginia B. Mattis et al. NEUROSCIENCE LETTERS
- Decreasing Disease Severity in Symptomatic, Smn−/−;SMN2+/+, Spinal Muscular Atrophy Mice Following scAAV9-SMN Delivery
- (2011) Jacqueline J. Glascock et al. HUMAN GENE THERAPY
- Increasing expression and decreasing degradation of SMN ameliorate the spinal muscular atrophy phenotype in mice
- (2011) Deborah Y. Kwon et al. HUMAN MOLECULAR GENETICS
- A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse
- (2011) Paul N. Porensky et al. HUMAN MOLECULAR GENETICS
- Discovery, Synthesis, and Biological Evaluation of Novel SMN Protein Modulators
- (2011) Jingbo Xiao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bifunctional RNAs Targeting the Intronic Splicing Silencer N1 Increase SMN Levels and Reduce Disease Severity in an Animal Model of Spinal Muscular Atrophy
- (2011) Erkan Y Osman et al. MOLECULAR THERAPY
- Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
- (2011) Yimin Hua et al. NATURE
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
- (2010) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- Splicing regulation of the Survival Motor Neuron genes and implications for treatment of spinal muscular atrophy
- (2010) Thomas et al. Frontiers in Bioscience-Landmark
- Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
- (2010) Y. Hua et al. GENES & DEVELOPMENT
- SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy
- (2010) Markus Riessland et al. HUMAN MOLECULAR GENETICS
- PTEN depletion rescues axonal growth defect and improves survival in SMN-deficient motor neurons
- (2010) Ke Ning et al. HUMAN MOLECULAR GENETICS
- Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice
- (2010) Elisa Dominguez et al. HUMAN MOLECULAR GENETICS
- Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model
- (2010) Mélissa Bowerman et al. HUMAN MOLECULAR GENETICS
- Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design
- (2010) F. D. Tiziano et al. JOURNAL OF MEDICAL GENETICS
- Exonic Sequences Provide Better Targets for Antisense Oligonucleotides Than Splice Site Sequences in the Modulation of Duchenne Muscular Dystrophy Splicing
- (2010) Annemieke Aartsma-Rus et al. OLIGONUCLEOTIDES
- Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy
- (2010) C. F. Valori et al. Science Translational Medicine
- Subcutaneous administration of TC007 reduces disease severity in an animal model of SMA
- (2009) Virginia B Mattis et al. BMC NEUROSCIENCE
- Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: implications for clinical trials and genetic counselling
- (2009) S Rudnik-Schöneborn et al. CLINICAL GENETICS
- Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model
- (2009) Virginia B. Mattis et al. HUMAN MOLECULAR GENETICS
- Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo
- (2009) Christopher R. Heier et al. HUMAN MOLECULAR GENETICS
- Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy
- (2009) Matthew E.R. Butchbach et al. HUMAN MOLECULAR GENETICS
- Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy
- (2009) T. D. Baughan et al. HUMAN MOLECULAR GENETICS
- Tetracyclines That Promote SMN2 Exon 7 Splicing as Therapeutics for Spinal Muscular Atrophy
- (2009) M. L. Hastings et al. Science Translational Medicine
- The SR protein family
- (2009) Peter J Shepard et al. GENOME BIOLOGY
- DcpS as a Therapeutic Target for Spinal Muscular Atrophy
- (2008) Jasbir Singh et al. ACS Chemical Biology
- Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice
- (2008) Yimin Hua et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A Negatively Acting Bifunctional RNA Increases Survival Motor Neuron Both In Vitro and In Vivo
- (2008) Alexa Dickson et al. HUMAN GENE THERAPY
- Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy
- (2008) Shingo Kariya et al. HUMAN MOLECULAR GENETICS
- Spinal muscular atrophy
- (2008) Mitchell R Lunn et al. LANCET
- Regulation of SMN Protein Stability
- (2008) B. G. Burnett et al. MOLECULAR AND CELLULAR BIOLOGY
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Daily salbutamol in young patients with SMA type II
- (2008) Marika Pane et al. NEUROMUSCULAR DISORDERS
- Plastin 3 Is a Protective Modifier of Autosomal Recessive Spinal Muscular Atrophy
- (2008) G. E. Oprea et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search